Current Drug Targets - CNS & Neurological Disorders
Title: Preface (Walter H. Kaye)
Volume: 2 Issue: 1
Author(s): Walter Kaye and Nicole Barbarich
Affiliation:
Export Options
About this article
Cite this article as:
Kaye Walter and Barbarich Nicole, Preface (Walter H. Kaye), Current Drug Targets - CNS & Neurological Disorders 2003; 2 (1) . https://dx.doi.org/10.2174/1568007X103020100iv
DOI https://dx.doi.org/10.2174/1568007X103020100iv |
Print ISSN 1568-007X |
Publisher Name Bentham Science Publisher |
Online ISSN 1568-007X |
12
Related Articles
-
Editorial: [Hot Topics: A New Horizon of Herbal Medicines in Anorexia-Cachexia Syndrome]
Current Pharmaceutical Design Kv7 Channels: Function, Pharmacology and Channel Modulators
Current Topics in Medicinal Chemistry Role of Psychiatrists in the Diagnosis and Management of Alzheimer's Disease “Revisited”: A Review and Clinical Opinion
Current Psychiatry Reviews Collecting Information for Rating Global Assessment of Functioning (GAF): Sources of Information and Methods for Information Collection
Current Psychiatry Reviews PLGA Nanoparticles for Nose to Brain Delivery of Clonazepam: Formulation, Optimization by 32 Factorial Design, In Vitro and In Vivo Evaluation
Current Drug Delivery Comparative Neurophysiologic Study of Pain in Patients with Parkinson's Disease and Patients with Persistent Pain After Spinal Surgery
Neuroscience and Biomedical Engineering (Discontinued) Adsorption and Bioactivity of Tyrosine Hydroxylase on Gold Surfaces and Nanoparticles
Protein & Peptide Letters Drug-Associated Mitochondrial Toxicity and its Detection
Current Medicinal Chemistry subject Index To Volume 2
Current Topics in Medicinal Chemistry Port-a-Patch and Patchliner: High Fidelity Electrophysiology for Secondary Screening and Safety Pharmacology
Combinatorial Chemistry & High Throughput Screening Selective Serotonin-norepinephrine Re-uptake Inhibition Limits Renovas-cular-hypertension Induced Cognitive Impairment, Endothelial Dysfunction, and Oxidative Stress Injury
Current Neurovascular Research Editorial [Hot Topic: Innate Immune Responses in CNS Neurodegenerative Diseases (Guest Editors: Hans van Noort and Sandra Amor)]
CNS & Neurological Disorders - Drug Targets Intranasal Drug Delivery for Brain Targeting
Current Drug Delivery Berberine Administration in Treatment of Colitis: A Review
Current Drug Targets A Review of Recent Patents on the ASICs as a Key Drug Target
Recent Patents on Biotechnology A Macro Role for Imprinted Clusters of MicroRNAs in the Brain
MicroRNA Effects of Tobacco Nicotine-Derived Nitrosamine Ketone (NNK) Exposures on Brain Alcohol Metabolizing Enzyme Activities
Drug Metabolism Letters Curcumin-glucoside, A Novel Synthetic Derivative of Curcumin, Inhibits α-Synuclein Oligomer Formation: Relevance to Parkinson's Disease
Current Pharmaceutical Design UDP-Glucuronosyltransferases
Current Drug Metabolism Nose to Brain Drug Delivery System: A Comprehensive Review
Drug Delivery Letters